兴齐眼药
(300573)
| 流通市值：131.43亿 | | | 总市值：171.15亿 |
| 流通股本：1.89亿 | | | 总股本：2.46亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 574,031,990.48 | 393,713,983.79 | 379,512,277.17 | 379,299,811.38 |
| 应收票据及应收账款 | 291,991,841.11 | 293,279,544.95 | 344,840,157.35 | 278,067,376.14 |
| 其中：应收票据 | 18,881,969.4 | 30,294,203.8 | 26,123,208.27 | 24,585,022.05 |
| 应收账款 | 273,109,871.71 | 262,985,341.15 | 318,716,949.08 | 253,482,354.09 |
| 应收款项融资 | 25,650,563.16 | 32,642,283.65 | 25,225,702.97 | 27,150,264.51 |
| 预付款项 | 19,126,482.72 | 15,219,192.33 | 20,969,214.72 | 19,882,207.56 |
| 其他应收款合计 | 2,777,686.24 | 2,093,276.24 | 2,229,203.82 | 1,822,610.04 |
| 存货 | 215,473,730.13 | 189,225,899.95 | 171,882,226.5 | 176,477,254.16 |
| 其他流动资产 | 3,685,724.34 | 4,558,263.41 | 35,513.79 | 111,934.59 |
| 流动资产合计 | 1,132,738,018.18 | 930,732,444.32 | 944,694,296.32 | 882,811,458.38 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 11,666,666.67 | 11,666,666.67 | 10,000,000 | 10,000,000 |
| 投资性房地产 | 10,898,873.18 | 11,132,420.45 | 11,365,967.72 | 11,599,514.99 |
| 固定资产 | 894,534,796.05 | 905,692,149.13 | 785,797,241.76 | 779,472,099.92 |
| 在建工程 | 394,460,369.6 | 380,257,761.9 | 376,436,600.51 | 286,191,938.59 |
| 使用权资产 | 12,980,977.77 | 14,917,872.45 | 15,873,255.51 | 17,390,550.84 |
| 无形资产 | 217,793,743.45 | 222,618,466.45 | 145,667,825.51 | 147,300,272.52 |
| 开发支出 | - | - | 72,337,441.19 | 68,284,205.85 |
| 长期待摊费用 | 2,758,417.47 | 3,398,769.96 | 4,039,122.45 | 4,544,445.61 |
| 递延所得税资产 | 20,184,265.94 | 19,684,388.11 | 27,748,101.94 | 23,239,478.56 |
| 其他非流动资产 | 50,903,759.07 | 38,876,769.29 | 25,512,053.42 | 36,513,449.26 |
| 非流动资产合计 | 1,616,181,869.2 | 1,608,245,264.41 | 1,474,777,610.01 | 1,384,535,956.14 |
| 资产总计 | 2,748,919,887.38 | 2,538,977,708.73 | 2,419,471,906.33 | 2,267,347,414.52 |
| 流动负债: | | | | |
| 短期借款 | 70,051,027.78 | 70,051,027.78 | 120,061,388.89 | 170,124,583.33 |
| 应付票据及应付账款 | 49,416,441.5 | 35,493,251.05 | 23,980,416.69 | 23,639,422.68 |
| 应付账款 | 49,416,441.5 | 35,493,251.05 | 23,980,416.69 | 23,639,422.68 |
| 预收款项 | 101,847.74 | 98,769.2 | 77,189.96 | 178,044.19 |
| 合同负债 | 3,241,650.93 | 1,785,209.49 | 1,594,126.94 | 1,746,680.57 |
| 应付职工薪酬 | 92,967,051.1 | 88,690,838.09 | 78,357,127.22 | 82,545,218.52 |
| 应交税费 | 75,051,965.22 | 73,280,270.47 | 95,519,806.29 | 44,260,311.36 |
| 其他应付款合计 | 193,082,501.3 | 204,203,685.88 | 149,685,230.35 | 90,790,833.42 |
| 一年内到期的非流动负债 | 7,431,030.69 | 7,599,917.12 | 8,070,443.96 | 8,325,165.3 |
| 其他流动负债 | 15,610,862 | 19,625,742.47 | 20,980,092.24 | 19,683,938.43 |
| 流动负债合计 | 506,954,378.26 | 500,828,711.55 | 498,325,822.54 | 441,294,197.8 |
| 非流动负债: | | | | |
| 租赁负债 | 3,457,103.99 | 4,377,543.17 | 5,782,344.06 | 7,489,159.94 |
| 递延收益 | 53,403,709.58 | 55,724,384.93 | 58,071,167.41 | 60,403,297.39 |
| 非流动负债合计 | 56,860,813.57 | 60,101,928.1 | 63,853,511.47 | 67,892,457.33 |
| 负债合计 | 563,815,191.83 | 560,930,639.65 | 562,179,334.01 | 509,186,655.13 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 246,429,527 | 246,429,527 | 245,348,945 | 245,348,945 |
| 资本公积 | 830,577,815.68 | 829,934,463.7 | 808,626,425.71 | 801,830,682.63 |
| 其他综合收益 | 1,416,666.67 | 1,416,666.67 | - | - |
| 盈余公积 | 123,214,763.5 | 123,214,763.5 | 87,624,623.5 | 87,624,623.5 |
| 未分配利润 | 983,465,922.7 | 777,051,648.21 | 715,692,578.11 | 623,356,508.26 |
| 归属于母公司股东权益合计 | 2,185,104,695.55 | 1,978,047,069.08 | 1,857,292,572.32 | 1,758,160,759.39 |
| 股东权益合计 | 2,185,104,695.55 | 1,978,047,069.08 | 1,857,292,572.32 | 1,758,160,759.39 |
| 负债和股东权益合计 | 2,748,919,887.38 | 2,538,977,708.73 | 2,419,471,906.33 | 2,267,347,414.52 |
| 公告日期 | 2026-04-28 | 2026-04-22 | 2025-10-29 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |